These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 639062)

  • 21. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some new aryl-sydnones: effects on murine tumours.
    Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
    Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antitumor activity of the components of a carminomycin complex].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
    Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
    Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
    Marks TA; Venditti JM
    Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical antitumor activity of bizelesin in mice.
    Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
    Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
    Sava G; Zorzet S; Mestroni G; Zassinovich G
    Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M; Komeshima N; Nakajima S; Tsuruo T
    Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenylthioalkylamines in experimental tumor treatment in mice.
    DiStefano V; Evans I; Myers-Robfogel M; Estes J; Godleski SA
    J Natl Cancer Inst; 1983 Dec; 71(6):1289-93. PubMed ID: 6581362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships.
    Catsoulacos P; Camoutsis C; Papageorgiou A; Adamiak-Margariti E
    Anticancer Res; 1992; 12(5):1617-20. PubMed ID: 1444229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity and antitumor activity of hexamethylmelamine and its N-demethylated metabolites in mice with transplantable tumors.
    Lake LM; Grunden EE; Johnson BM
    Cancer Res; 1975 Oct; 35(10):2858-63. PubMed ID: 808270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapeutic characterization in mice of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfinamide (sulfinosine), a novel purine nucleoside with unique antitumor properties.
    Avery TL; Finch RA; Vasquez KM; Radparvar S; Hanna NB; Revankar GR; Robins RK
    Cancer Res; 1990 May; 50(9):2625-30. PubMed ID: 2328488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.
    Wick MM
    Cancer Treat Rep; 1979 Jun; 63(6):991-7. PubMed ID: 466656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antitumor effect of a benzoylphenylurea derivative HO-221].
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.